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Abstract. 
 
In renal principal cells, vasopressin regulates
the shuttling of the aquaporin (AQP)2 water channel
between intracellular vesicles and the apical plasma
membrane. Vasopressin-induced phosphorylation of
AQP2 at serine 256 (S256) by protein kinase A (PKA)
is essential for its localization in the membrane. How-
ever, phosphorylated AQP2 (p-AQP2) has also been
detected in intracellular vesicles of noninduced princi-
pal cells. As AQP2 is expressed as homotetramers, we
hypothesized that the number of p-AQP2 monomers in
a tetramer might be critical for the its steady state dis-
tribution. Expressed in oocytes, AQP2-S256D and
AQP2-S256A mimicked p-AQP2 and non–p-AQP2, re-
spectively, as routing and function of AQP2-S256D and
wild-type AQP2 (wt-AQP2) were identical, whereas
AQP2-S256A was retained intracellularly. In coin-
jection experiments, AQP2-S256A and AQP2-S256D
formed heterotetramers. Coinjection of different ratios
of AQP2-S256A and AQP2-S256D cRNAs revealed
that minimally three AQP2-S256D monomers in an
AQP2 tetramer were essential for its plasma membrane
localization. Therefore, our results suggest that in prin-
cipal cells, minimally three monomers per AQP2 tet-
 
ramer have to be phosphorylated for its steady state
localization in the apical membrane. As other multisub-
unit channels are also regulated by phosphorylation, it
is anticipated that the stoichiometry of their phos-
phorylated and nonphosphorylated subunits may ﬁne-
tune the activity or subcellular localization of these
complexes.
Key words: oocytes • trafﬁcking • water channels •
kidney • oligomerization
 
Introduction
 
To maintain water balance, the human kidney forms 1.5 li-
ters of urine daily out of 180 liters of glomerular filtrate by
water reabsorption, which occurs mainly through aqua-
porin (AQP)
 
1
 
 1 and AQP2 water channels (Deen et al.,
1994; Nielsen et al., 1998; Schnermann et al., 1998). Al-
most 90% of this water is constitutively reabsorbed in
proximal tubules and descending limbs of Henle, where
AQP1 is present in the apical and the basolateral plasma
membrane (Nielsen et al., 1993). Principal cells of the re-
nal collecting duct concentrate the remaining volume via
AQP2 in the apical plasma membrane and via AQP3 and
AQP4 in the basolateral plasma membrane, a process that
is tightly regulated by the antidiuretic hormone arginine
vasopressin (AVP) (Deen and Knoers, 1998; Nielsen et al.,
1999). The mechanism responsible for this hormonal re-
sponse is believed to involve a cycle of exo- and endocyto-
sis, during which vesicles containing AQP2 water channels
are shuttled between the apical plasma membrane and an
intracellular endosomal compartment (Wade et al., 1981;
Brown, 1989; Harris et al., 1991; Ecelbarger et al., 1995;
Terris et al., 1995). In fully hydrated states, circulating
AVP levels are low and the main steady state localization
of AQP2 will be in intracellular vesicles. In contrast, states
of hypernatremia or hypovolemia will increase circulating
levels of AVP, which will bind to its V2 receptor, activate
protein kinase A (PKA) via a cAMP signaling cascade,
and initiate a redistribution of AQP2 from intracellular
vesicles to the apical plasma membrane (Marples et al.,
1995; Nielsen et al., 1995a; Sabolic et al., 1995). However,
in both steady states AQP2 water channels are thought to
be continually removed from the apical membrane by
clathrin-mediated endocytosis (Brown et al., 1988; Strange
et al., 1988), and the steady state number of channels in
the membrane is thought to reflect a balance between exo-
cytotic insertion and endocytotic retrieval processes (Kat-
sura et al., 1996).
Since its discovery (Fushimi et al., 1993), AQP2 has
been shown to be of prime importance in the pathophysi-
ology of acquired and hereditary water balance disorders.
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Lithium treatment, bilateral ureteral obstruction, nephro-
sis, hypokalemia, or defects in the gene coding for AQP2
have been shown to correspond with decreased AQP2 lev-
els and vesicular localization of AQP2, resulting in diure-
sis. In contrast, congestive heart failure, the syndrome of
inappropriate secretion of AVP (SIADH), liver cirrhosis,
preeclampsia, and nephrotic syndrome correlate with ele-
vated levels of AQP2, which is predominantly expressed in
the apical membrane. As a consequence, water reabsorp-
tion increases, leading to hyponatremia (for reviews see
Deen and Knoers, 1998; Martin and Schrier, 1998; Nielsen
et al., 1999). In both disease states, the redistribution of
AQP2 thus plays an important role.
The identification of a cAMP-dependent PKA consen-
sus site in AQP2 indicated that, besides other proteins,
phosphorylation of AQP2 itself might be essential for
its AVP-induced redistribution to the apical membrane
(Fushimi et al., 1993). Indeed, PKA appeared to phosphor-
ylate serine 256 (S256) in AQP2 (Kuwahara et al., 1995;
Mulders et al., 1998; Nishimoto et al., 1999) without in-
creasing its single unit water conductivity (Lande et al.,
1996). Analysis in transfected LLC-PK
 
1
 
 cells revealed that
an AVP-induced redistribution of AQP2 to the plasma
membrane was inhibited by the PKA-specific inhibitor
 
N
 
-(2([3-(4-bromophenyl)-2-propenyl]-amino)-ethyl)-5-iso-
quinolinesulfonamide (H89), and that the localization of
AQP2-S256A, which mimics nonphosphorylated AQP2
(non–p-AQP2), remained in intracellular vesicles upon
treatment with AVP (Fushimi et al., 1997; Katsura et al.,
1997). As phosphorylation of AQP2 at S256 appeared to
be essential for its AVP-induced redistribution to the api-
cal membrane, the observation that in kidneys of fully hy-
drated rats intracellularly located AQP2 is already phos-
phorylated was surprising (Christensen et al., 2000).
As AQP2 is expressed as homotetramers (Kamsteeg et
al., 1999), we hypothesized that the number of p-AQP2
monomers in a tetramer might be critical for the main
steady state localization of AQP2. Because the expression
level of exogenous proteins can be tightly regulated in 
 
Xe-
nopus
 
 oocytes, we studied phosphorylation of AQP2 in
these cells. In addition, we showed that the issue whether
the number of p-AQP2 monomers in a tetramer deter-
mines its distribution could be addressed in oocytes, and,
finally, determined which stoichiometry of p-AQP2/non–
p-AQP2 in an AQP2 tetramer is necessary for expression
of the complex in the plasma membrane.
 
Materials and Methods
 
Constructs and In Vitro Transcription
 
pT
 
7
 
T
 
s
 
 constructs encoding wild-type AQP2 (wt-AQP2), AQP2-E258K,
AQP2-R187C, AQP2-R253*, or AQP2-S256A were as described (Deen
et al., 1994; Mulders et al., 1998). The cDNA coding for Flag-tagged
AQP2-S256D (AQP2-S256D-F) was constructed by a three point PCR re-
action. A forward primer 5
 
9
 
-GAGCGCGAGGTGCGACGTCGGCAG-
 
GAC
 
GTGGAGCTGCACTCGCC-3
 
9
 
, which encodes the S256D muta-
tion (bold) and a silent mutation introducing an AatII restriction site
(underlined), was combined with the T
 
3
 
 RNA polymerase primer (Amer-
sham Pharmacia Biotech) to amplify the last 70 bp of the COOH terminus
of AQP2 from the human AQP2 cDNA in pBluescript (pBS-AQP2; Deen
et al., 1994). The obtained PCR fragment was isolated from gel, then
mixed with KpnI-linearized pBS-AQP2 as a second template, T
 
3
 
 RNA
polymerase primer, and the AQP2 primer 533F (5
 
9
 
-CCCCTGCTCTCTC-
CATAGGC-3
 
9
 
), which corresponds to nucleotides 550–570 of the AQP2
cDNA sequence, to amplify a 350-bp DNA fragment. This fragment was
 
digested with BamHI and KpnI, and a 282-bp AQP2 cDNA fragment was
isolated from gel and cloned into the corresponding sites of pT
 
7
 
T
 
S
 
-
5
 
9
 
FLAG-wt-AQP2 (Kamsteeg et al., 1999). The three pT
 
7
 
T
 
S
 
 constructs
were linearized with SalI, and g-capped cRNA transcripts were synthe-
sized in vitro as described (Deen et al., 1995). The cRNAs were purified
and dissolved in DEPC-treated water. The integrity of the cRNAs was
checked by agarose gel electrophoresis and their concentrations were de-
termined with a spectrophotometer.
 
Isolation and Injection of Xenopus Oocytes
 
Oocytes were isolated from 
 
Xenopus laevis
 
 and defolliculated by digestion
at room temperature for 2 h with 2 mg/ml collagenase A (Boehringer) in
modified Barth’s solution (MBS: 88 mM NaCl, 1 mM KCl, 2.4 mM
NaHCO
 
3
 
, 10 mM Hepes, pH 7.5, 0.82 mM MgSO
 
4
 
, 0.33 mM Ca[NO
 
3
 
]
 
2
 
,
0.41 mM CaCl
 
2
 
, and 25 
 
m
 
g/ml gentamicin). Stage V and VI oocytes were
selected and stored at 18
 
8
 
C in MBS. Oocytes were (co)injected with a to-
tal of 0.4 ng of wild-type and/or mutant AQP2 cRNA and 2 d after injec-
tion were analyzed in a standard swelling assay.
 
Water Permeability Measurements
 
Oocytes. 
 
The osmotic water permeability (Pf) of individual oocytes was as-
sayed at 18
 
8
 
C from the time course of oocyte swelling in response to a 10-
fold dilution of MBS with water. Relative oocyte volume was averaged in 1-s
time intervals by a real time imaging method as described (Zhang et al.,
1990). Osmotic water permeability (in 
 
m
 
m/s) was calculated from the initial
rates of swelling, d(
 
V
 
/
 
V
 
o
 
)/
 
dt
 
, oocyte surface-to-volume ratio (
 
S
 
/
 
V
 
o
 
 
 
= 
 
5 
 
3
 
10
 
2
 
5
 
 cm
 
2
 
1
 
), and partial molar volume of water (
 
V
 
w
 
 = 18 cm
 
3
 
/mol) from the
relation: Pf = [d(
 
V
 
/
 
V
 
o
 
)/
 
dt
 
]/[(
 
S
 
/
 
V
 
o
 
)V
 
w
 
 
 
3 
 
(osm
 
out
 
 
 
2 
 
osm
 
in
 
)], where osm
 
out
 
 
 
2
 
osm
 
in
 
 = 180 mOsmol. d(
 
V
 
/
 
V
 
o
 
)/
 
dt
 
 was determined from the initial slope of a
quadratic polynomial fitted to the first 30 s of the swelling time course. Per
experiment, oocytes from the same batch were used. The mean Pf values
were measured for at least 12 oocytes and the mean Pf values of noninjected
oocytes varied from 6 to 12 
 
m
 
m/s between different oocyte batches.
 
MDCK Cells. 
 
Native MDCK-HRS cells and MDCK cells stably ex-
pressing human AQP2 (wt10; Deen et al., 1997a) were grown in DME
supplemented with 5% FCS at 37
 
8
 
C in 5% CO
 
2
 
. To test the activity of H89
or 8-bromo-adenosine cAMP (8-Br-cAMP; Sigma-Aldrich) on the AQP2-
mediated water permeability of wt10 cells, the cells were grown on semi-
permeable inserts and subjected to a standard transcellular osmotic water
transport assay as described (Deen et al., 1997b). During the entire assay
period, 10
 
2 
 
7 
 
M forskolin with or without 10
 
2
 
4
 
 M H89 or just 5 
 
3
 
 10
 
2
 
4
 
 M
8-Br-cAMP was added to the medium of both sides of the inserts.
 
[
 
32
 
P]Orthophosphate Labeling and 
Immunoprecipitation of AQP2
 
Vitellin membrane–stripped oocytes, injected with wt-AQP2 or AQP2-
S256A cRNA, were directly incubated in MBS with 20 
 
m
 
Ci/ml [
 
32
 
P]ortho-
phosphate (Amersham Pharmacia Biotech) for 2 d. Then, oocytes ex-
pressing wt-AQP2 were left untreated, were incubated with 10
 
2
 
4
 
 M H89
for the entire labeling period or for 1 h, or were incubated with 5 
 
3
 
 10
 
2
 
4
 
 M
8-Br-cAMP for 5, 10, or 30 min. Next, oocytes were homogenized in ho-
mogenization buffer A (HbA: 20 mM Tris, pH 7.4, 5 mM MgCl
 
2
 
, 5 mM
NaH
 
2
 
PO
 
4
 
, 1 mM EDTA, 80 mM sucrose, 1 mM PMSF, 5 
 
m
 
g/ml leupeptin
and pepstatin A), supplemented with 10 mM NaF and 0.5 M Na
 
3
 
VO
 
4
 
 to
inhibit dephosphorylation, and total membranes were isolated and solubi-
lized in 500 
 
m
 
l membrane solubilization buffer (MSB: 100 mM Tris-HCl,
pH 8.3, 150 mM NaCl, 0.5%Na deoxycholate, 0.1% SDS, 0.5% NP-40, 2
mM EDTA, 1 mM PMSF, 5 
 
m
 
g/ml leupeptin, and 5 
 
m
 
g/ml pepstatin), 10
mM NaF, and 0.5 M Na
 
3
 
VO
 
4
 
. 10-
 
m
 
l equivalents of protein A–agarose
beads (Biozym) were preincubated for 12 h at 4
 
8
 
C with 2 
 
m
 
l rabbit 7
AQP2 antibodies in MSB, 0.1% BSA. These antibodies were raised
against the 15 COOH-terminal amino acids of rat AQP2 (Deen et al.,
1995). The washed antibody-bound beads were incubated with solubilized
membranes for 16 h, washed three times with MSB, 10 mM NaF, and 0.5 M
Na
 
3
 
VO
 
4
 
, resuspended in 15 
 
m
 
l of Laemmli buffer (2% SDS, 50 mM Tris,
pH 6.8, 12% glycerol, 0.01% Coomassie Brilliant Blue, 100 mM DTT), 10
mM NaF, and 0.5 M Na
 
3
 
VO
 
4
 
, and incubated at 37
 
8
 
C for 30 min. The sam-
ples were then subjected to PAGE, and the gel was dried and autoradio-
graphed for 1 d.
 
Isolation of Total and Plasma Membranes
 
For the isolation of total membranes, oocytes were homogenized in 20 
 
m
 
l
HbA/oocyte and centrifuged twice for 5 min each at 200 
 
g
 
 and 4
 
8
 
C. Next, 
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membranes were isolated by 20-min centrifugation at 4
 
8
 
C and 14,000 
 
g
 
and resuspended in 15 
 
m
 
l of Laemmli buffer. The isolation of plasma
membranes was done essentially according to Oh and Schnitzer (1998)
with some modifications. Essentially, oocytes were stripped from their vi-
tellin membrane and rotated in 1% colloidal silica, Ludox Cl (Sigma-
Aldrich) in MES buffered saline for silica (MBSS: 20 mM MES, 80 mM
NaCl, pH 6.0) for 30 min at room temperature, washed three times in
MBSS, rotated in 0.1% polyacrylic acid (Sigma-Aldrich) in MBSS for 30
min at room temperature, and washed three times in MBS. Subsequently,
oocytes were homogenized in 1,200 
 
m
 
l HbA at 4
 
8
 
C and centrifuged for 30 s
at 13.5 
 
g
 
 and 4
 
8
 
C, after which 1 ml of the top of the sample was removed
and 1 ml of HbA was added. This centrifugation and exchange of HbA
was repeated four times, but centrifugation changed from twice at 13.5 
 
g
 
via once at 24 
 
g
 
 to once at 38 
 
g
 
. After the last centrifugation step, HbA
was removed and plasma membranes were spun down for 20 min at maxi-
mum speed and 4
 
8
 
C and resuspended in 15 
 
m
 
l of Laemmli buffer.
 
Immunoblotting
 
Protein samples were denatured by incubation for 30 min at 37
 
8
 
C in Laem-
mli buffer, subjected to electrophoresis on a 12% SDS-polyacrylamide gel,
and immunoblotted onto PVDF membranes (Millipore) by standard pro-
cedures. Membranes were blocked for 1 h in 5% nonfat dried milk in TBS-
T (TBS with 0.1% Tween 20). Subsequently, membranes were incubated
overnight with 1:3,000-diluted affinity-purified rabbit 7 IgGs, diluted in
TBS-T supplemented with 1% nonfat dried milk. Blots were then incu-
bated for 1 h with 1:5,000-diluted goat anti–rabbit IgG (Sigma-Aldrich)
coupled to horseradish peroxidase. Finally, AQP2 proteins were visualized
using enhanced chemiluminescence (Pierce Chemical Co.).
 
Immunocytochemistry
 
Oocytes were stripped from their vitelline membranes, fixed in 1% (wt/
vol) paraformaldehyde-lysine-periodate (PLP; McLean and Nakane,
1974), dehydrated, and embedded in paraffin. 5-
 
m
 
m sections were cut,
stretched in 37
 
8
 
C water, dried upon gelatin-coated object glass (Menzel
Gläser) for at least 1 h at 37
 
8
 
C, deparaffinized with xylol, and rehydrated
with a 100, 96, 90, 80, 70, and 50% ethanol series and finally water. Oocyte
sections were treated with 0.1% Triton X-100, quenched with 50 mM
NH
 
4
 
Cl in TBS, blocked for 30 min in 10% goat serum in TBS, and incu-
bated with 1:50-diluted affinity-purified rabbit 7 AQP2:257–271 antibod-
ies for 16 h in TBS with 10% goat serum. Subsequently, the sections were
washed three times in TBS and incubated in 1:300-diluted goat anti–rabbit
IgG, coupled to Alexa-594 (Molecular Probes) in TBS with 10% goat se-
rum for 1 h. After three TBS washes and dehydration with ethanol, the
section were mounted in Vectashield (Vector Laboratories).
 
Sucrose Gradient Sedimentation Centrifugation
 
Oocyte membranes were dissolved in solubilization buffer (4% Na deoxy-
cholate, 20 mM Tris, pH 8.0, 5 mM EDTA, 10% glycerol, 1 mM PMSF, 5
 
m
 
g/ml leupeptin and pepstatin) for 1 h at 37
 
8
 
C and centrifuged at 100,000 
 
g
 
for 1 h at 4
 
8
 
C to remove undissolved membranes, essentially as described
(Neely et al., 1999). Sedimentation by gradient centrifugation was done
essentially as described (Jung et al., 1994). 5–17.5% sucrose gradients
were prepared of 533 
 
m
 
l of 5, 7.5, 10, 12.5, 15, and 17.5% sucrose each in
20 mM Tris, pH 8.0, 5 mM EDTA, 0.1% Triton X-100, 1 mM PMSF, and 5
 
m
 
g/ml leupeptin and pepstatin. 300-
 
m
 
l samples of membrane proteins in
Na deoxycholate were loaded and subjected to 150,000 
 
g
 
 centrifugation
for 16 h at 8
 
8
 
C. 200-
 
m
 
l fractions were taken off carefully, designated A
through S, and analyzed by immunoblotting. As sedimentation markers, a
mixture of ovalbumin (43 kD), BSA (67 kD), phosphorylase B (97 kD),
yeast alcohol dehydrogenase (150 kD), and catalase (232 kD) was used.
All markers were from Sigma-Aldrich.
 
Immunoprecipitation of AQP2 Proteins with
FLAG Antibodies
 
Membranes of 30 oocytes (co)expressing AQP2 mutants were dissolved in
200 
 
m
 
l solubilization buffer (4% Na deoxycholate, 20 mM Tris, pH 8.0, 5
mM EDTA, 10% glycerol, 1 mM PMSF, 5 
 
m
 
g/ml leupeptin and pepstatin)
for 1 h at 37
 
8
 
C and centrifuged at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C to remove undis-
solved membranes as described (Kamsteeg et al., 1999). 15-
 
m
 
l equivalents
of protein G–agarose beads (Amersham Pharmacia Biotech) were prein-
cubated for 12 h at 4
 
8
 
C with 1 
 
m
 
l monoclonal FLAG antibody (m2; Sigma-
Aldrich) in IPP500 (500 mM NaCl, 10 mM Tris, pH 8.0, 0.1% NP-40, 0.1%
Tween 20, 1 mM PMSF, and 5 
 
m
 
g/ml leupeptin and pepstatin A) and 0.1%
 
BSA. The solubilized membranes were diluted with 600 
 
m
 
l 10% sucrose,
and NaCl was added to a final concentration of 100 mM. Next, the washed
antibody-bound protein G beads were incubated for 4 h at 4
 
8
 
C with the
solubilized membranes, washed three times with IPP100 (100 mM NaCl,
10 mM Tris, pH 8.0, 0.1% NP-40, 0.1% Tween 20, 1 mM PMSF, and 5 
 
m
 
g/
ml leupeptin and pepstatin A), dissolved in 30 
 
ml Laemmli buffer, and
subjected to immunoblotting.
Densitometrical Analysis of Protein Signals
Parallel to the coinjections, a twofold dilution series of total membranes
of oocytes expressing wt-AQP2 was immunoblotted. Each signal was
scanned with a GS-690 Imaging Densitometer (Bio-Rad Laboratories)
and quantified with the “molecular analyst” analysis program (Bio-Rad
Laboratories). Only signals in the linear exposure range of the films were
used. The densities of the twofold dilution series of wt-AQP2 were used as
a (linear) standard for semiquantification of the amounts of expressed
AQP2 (arbitrary units) in the coinjections.
Statistical Analyses
Statistical significance of the similarity between the observed Pf values and
expected Pf values was determined by analysis of variance with StatView
(Abacus Concepts, Inc.). P values , 0.05 were considered significant.
Results
The process of continuous recycling appears to be a gen-
eral phenomenon for many membrane proteins in many
cell types, including oocytes (Morrill et al., 1984; Brown et
al., 1988; Quick et al., 1997; Staub et al., 1997; Ghosh et al.,
1998; Bao et al., 2000; Rohn et al., 2000). Therefore, this is
also likely to occur for AQP2, heterologously expressed in
oocytes. As all data obtained in this study are obtained in
steady states, the term “localization” will be used for the
predominant subcellular localization of the protein in a
particular steady state.
In Oocytes, Phosphorylation of S256 in wt-AQP2 Is Not 
Changed by cAMP or H89
To determine whether in oocytes wt-AQP2 is phosphory-
lated at S256 and whether the level of phosphorylation can
be modulated, oocytes were injected with cRNA encoding
wt-AQP2 or the nonphosphorylatable mutant AQP2-
S256A. 3 d after injection and [32P]orthophosphate label-
ing, AQP2 was immunoprecipitated and subjected to
PAGE. Autoradiography showed that wt-AQP2 was
phosphorylated, whereas AQP2-S256A was not (Fig. 1,
p-AQP2), indicating that in wt-AQP2 only S256 was phos-
phorylated. The absence of AQP2-S256A labeling was not
caused by differences in expression levels (Fig. 1, Total
AQP2). Treatment of oocytes for 5, 10, or 30 min with
8-Br-cAMP or incubation with the PKA inhibitor H89 did
not change the level of wt-AQP2 phosphorylation (Fig. 1).
Although shown for one example, all conditions were
done in triplicate and the scanned signals were normalized
for the total amount of expressed AQP2. Also, osmotic
water permeability (Pf) measurements revealed no differ-
ences between AQP2-expressing oocytes incubated with
or without 8-Br-cAMP or H89 (not shown). To check
whether 8-Br-cAMP and H89 were still active as drugs,
both were tested on MDCK cells that stably express
AQP2 (wt10 cells). Water permeability measurements
(Pf 6 SEM in mm/s) revealed that 8-Br-cAMP increased
the Pf from 9.4 6 1 to 24.7 6 1, whereas H89 partially re-
duced forskolin-stimulated Pf from 23.1 6 0.6 to 19.4 6
0.9. This indicated that both agents exerted their expectedThe Journal of Cell Biology, Volume 151, 2000 922
effects on AQP2 routing in mammalian cells. All together,
these results clearly showed that in oocytes, wt-AQP2 is
phosphorylated at S256, but the level of phosphorylation is
not changed by 8-Br-cAMP or H89.
AQP2-S256A Is Retained Inside the Cell, Whereas the 
Routing and Function of AQP2-S256D Are Identical to 
Those of wt-AQP2
Expressed in LLC-PK1 cells, forskolin redistributed wt-
AQP2 to the plasma membrane, whereas AQP2-S256A
remained in vesicles, as anticipated for nonphosphorylated
AQP2 (Katsura et al., 1997). To mimic p-AQP2, AQP2-
S256D was generated and was NH2-terminally tagged with
a FLAG epitope (AQP2-S256D-F) to distinguish it from
AQP2-S256A and to be able to specifically immunopre-
cipitate AQP2-S256D in the case of coinjections. To reveal
whether AQP2-S256A and AQP2-S256D-F mimic non–
p-AQP2 and p-AQP2, respectively, their characteristics in
oocytes were determined.
2 d after injection, the Pf of oocytes expressing AQP2-
S256D-F was not different from that of oocytes expressing
wt-AQP2, whereas the Pf of oocytes expressing AQP2-
S256A was as that of control oocytes (Fig. 2 A). Immuno-
blotting of total membranes of these oocytes showed iden-
tical expression levels of wt-AQP2, AQP2-S256A, and
AQP2-S256D-F, whereas plasma membrane samples of
these oocytes revealed a strongly decreased signal for
AQP2-S256A only (Fig. 2 B). Immunocytochemistry per-
formed on sections of these oocytes revealed that wt-
AQP2 and AQP2-S256D-F were present in the plasma
membrane (Fig. 3; wt and SD, respectively), whereas
AQP2-S256A was present in an organelle just below the
plasma membrane, possibly vesicles (Fig. 3; SA). This
staining was specific for AQP2, because control oocytes
were unstained (Fig. 3; ctrl). These results showed that
AQP2-S256A was mainly intracellularly localized, whereas
the localization of AQP2-S256D-F was identical to that of
wt-AQP2, namely in the plasma membrane. Furthermore,
the function of AQP2-S256D was identical to that of wt-
AQP2. Therefore, it can be concluded that AQP2-S256A
mimics non–p-AQP2 and that AQP2-S256D-F mimics
p-AQP2.
AQP2-S256A and AQP2-S256D-F
Form Heterotetramers
To be able to determine the stoichiometry of p-AQP2/
non–p-AQP2, it is essential that the amino acids at or close
to S256 are not involved in the formation of homotetra-
mers and that AQP2-S256A and AQP2-S256D-F form
heterotetramers. To reveal the importance of amino acids
at or close to S256 on the ability to form homotetramers,
membranes of oocytes expressing wt-AQP2, AQP2-
S256A, AQP2-S256D-F, AQP2-R253* (an AQP2 protein
that misses the COOH-terminal amino acids R253–T269),
Figure 1. Phosphorylation of AQP2 in oocytes. Oocytes, injected
with wt-AQP2 or AQP2-S256A cRNA, were labeled with
[32P]orthophosphate for 2 d. Subsequently, oocytes were not
stimulated (ctrl, AQP2-S256A), or were incubated with 5 3 1024 M
8-Br-cAMP or 1024 M H89 for the indicated time periods. Total
membranes were isolated and divided into two portions. One
portion was solubilized, AQP2 was immunoprecipitated and sub-
jected to PAGE, the gel was dried, and labeled AQP2 (p-AQP2)
was visualized using autoradiography. The other portion was di-
rectly immunoblotted for AQP2 (Total AQP2).
Figure 2. Osmotic water permeability (Pf) and immunoblot analy-
sis of oocytes expressing wild-type or mutant AQP2. (A) Oocytes
were not injected (control), or were injected with cRNA encoding
wt-AQP2, AQP2-S256A, or AQP2-S256D-F. 2 d after injection,
the mean Pfs 6 SEM (in mm/s) of at least 12 oocytes were deter-
mined in a standard swelling assay. (B) From the oocytes that
were used for the Pf measurements, total membranes and plasma
membranes were isolated and immunoblotted for AQP2.Kamsteeg et al. Stoichiometry of (Non)phosphorylated AQP2 Subunits 923
or AQP2-R187C (an ER-retained mutant in recessive
nephrogenic diabetes insipidus [NDI]) were solubilized in
desoxycholate and subjected to sucrose gradient sedimen-
tation centrifugation. Immunoblotting of fractions taken
from these gradients revealed that wt-AQP2, AQP2-
S256A, and AQP2-S256D-F had their peak intensities in
fraction K (Fig. 4 A). On the basis of the peak fractions of
sedimentation marker proteins, the molecular masses of
proteins in fraction K are between 97 and 150 kD, which
corresponds with a homotetramer for the AQP2 proteins,
since an AQP2 monomer is 29 kD. AQP2-R253* had a
slightly lower sedimentation value (peak fraction J), which
is presumably due to the 2-kD difference in molecular
mass between AQP2-R253* and wt-AQP2. AQP2-R187C,
which is expressed as an unglycosylated and high-mannose
glycosylated form (Deen et al., 1995), peaked in fraction G
(Fig. 4 A). As shown previously for AQP2-R187C, this
fraction corresponds to a monomeric form of AQP2 (Kam-
steeg et al., 1999). On the basis of these data, it was con-
cluded that mutations at or close to S256 do not interfere
with homotetramerization of AQP2 proteins.
To determine whether AQP2-S256A and AQP2-
S256D-F can form heterotetramers, oocytes were injected
with cRNA encoding AQP2-S256A alone or in combina-
tion with AQP2-S256D-F. Immunoblots of immunoprecip-
itates with FLAG antibodies of total membranes of these
oocytes revealed that AQP2-S256A coprecipitated with
AQP2-S256D-F (Fig. 4 B). The absence of AQP2-S256A
in the immunoprecipitate from oocytes expressing just
AQP2-S256A revealed the specificity of the FLAG-tag
immunoprecipitations and was not a consequence of low
expression, as the signal for AQP2-S256A in total mem-
branes of these oocytes was even stronger than in oocytes
coexpressing AQP2-S256D-F and AQP2-S256A (Fig. 4
B). Therefore, it was concluded that AQP2-S256D-F and
AQP2-S256A form heterotetramers.
Three AQP2-S256D-F Monomers Are Required for 
Predominant Localization of an AQP2 Tetramer in the 
Oocyte Plasma Membrane
Since, with low expression levels, AQP2-S256A was pre-
dominantly retained inside the cell, AQP2-S256D-F func-
tioned as wt-AQP2, and the mutants formed heterotetra-
mers upon coexpression, the prerequisites were fulfilled for
using AQP2-S256A and AQP2-S256D-F to determine the
stoichiometry of p-AQP2/non–p-AQP2 in an AQP2 tet-
ramer that is necessary for a predominant steady state lo-
calization of AQP2 in the plasma membrane. Determina-
tion of this stoichiometry needed: coinjection of oocytes
with cRNA of AQP2-S256D-F and AQP2-S256A; calcula-
Figure 3. Immunocytochemistry of oocytes expressing wild-type or mutant AQP2 proteins. 2 d after injection, oocytes injected with
cRNA encoding wt-AQP2 (wt), AQP2-S256A (SA), or AQP2-S256D-F (SD), and noninjected oocytes (ctrl) were fixed and embedded
in paraffin. In 5-mm sections, AQP2 was visualized using rabbit AQP2 antibodies followed by Alexa-594–conjugated anti–rabbit IgG.
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tion of their expected Pf values for the requirement of zero,
one, two, three, or four AQP2-S256D-F monomers per tet-
ramer for plasma membrane localization; and comparison
of the expected Pf values with the observed Pf values.
Coinjection. cRNAs of AQP2-S256D-F and AQP2-
S256A were mixed in the ratios 3:1, 2:1, 1:1, 1:2, and 1:3,
and a total of 0.4 ng cRNA was injected, along with a dilu-
tion series of AQP2-S256D-F cRNA.
Calculation of Expected Pf Values. For the calculation of
the expected Pf values, it was required to obtain (a) the to-
tal amount of AQP2 protein per coinjection, (b) the ratio
of expressed AQP2-S256D-F and AQP2-S256A in each
injection, (c) the fraction of the total protein per injection
that is expected to be expressed in the plasma membrane
when zero, one, two, three, or four AQP2-S256D-F mono-
mers per tetramer are required for plasma membrane lo-
calization, and (d) the relation between the amount of
AQP2 expressed in the plasma membrane and its Pf.
After measuring the Pf values of the coinjected oocytes
(see Table II), total membranes were isolated and immu-
noblotted. The antibodies used had identical avidity for
AQP2-S256A and AQP2-S256D-F (not shown). The den-
sities of individual signals were scanned and compared
with a parallel blotted dilution series of wt-AQP2 to calcu-
late the amounts of AQP2 (in arbitrary units). These were
then used to calculate the total amounts of expressed
AQP2 (Fig. 5; Total AQP2, in arbitrary units) and the ra-
tio between the amounts of AQP2-S256D-F/AQP2-S256A
proteins (Fig. 5; Ratio SD/SA) in the five coexpressions.
Assuming random formation of (hetero)tetramers, the
frequencies of all five possible tetramers (ranging from
tetramers containing four AQP2-S256A to tetramers con-
taining four AQP2-S256D-F monomers) were calculated
for each AQP2-S256D-F (SD)/AQP2-S256A (SA) ratio.
Subsequently, for each SD/SA ratio, the fraction of the to-
tal protein that would be localized in the plasma mem-
brane was calculated for when zero, one, two, three, or
four AQP2-S256D-F monomers per tetramer are required
for plasma membrane localization by adding up the fre-
quencies of tetramers that match each requirement (col-
umns AAAA through DDDD in Table I, respectively).
Multiplication of the total amounts of expressed AQP2 in
the coinjections (Fig. 5) with the fractions of protein that
would be localized in the plasma membrane (Table I) re-
vealed the total amounts of protein (in arbitrary units) at
that location for each requirement.
From the Pf values and immunoblot signals of oocytes ex-
pressing AQP2-S256D-F, which is completely localized in
the plasma membrane, the relation between Pf and AQP2
amount in the plasma membrane was obtained (Pf = [3.97 3
amount of AQP2 protein expected in the membrane] 2 9.7)
(Fig. 6). Using this relation and the calculated expected
amounts of AQP2 protein expressed in the plasma mem-
brane when zero, one, two, three, or four AQP2-S256D-F
Figure 4. Oligomerization
state of AQP2 proteins and
coimmunoprecipitation of
AQP2-S256A with AQP2-
S256D-F. (A) Oocytes were
injected with cRNAs encod-
ing wt-AQP2, AQP2-S256A,
AQP2-S256D-F, AQP2-
R253*, or AQP2-R187C. 3 d
after injection, membranes
of these oocytes were solubi-
lized in 4% deoxycholate and subjected to sucrose gradient sedi-
mentation centrifugation. Fractions were collected from the top,
of which fractions B–P were immunoblotted for AQP2. The frac-
tions with peak intensities of the marker proteins ovalbumin,
BSA, phosphorylase B, yeast alcohol dehydrogenase, and cata-
lase are indicated by their molecular masses (45, 67, 97, 150, and
232, respectively). The molecular masses (in kD) of the AQP2
proteins are indicated on the left. (B) Membranes of oocytes ex-
pressing AQP2-S256A alone (SA) or in combination with AQP2-
S256D-F (SD-F 1 SA) were directly subjected to immuno-
blotting for AQP2 (Total membranes) or first solubilized in
deoxycholate, immunoprecipitated with FLAG antibodies, and
then subjected to immunoblotting (Immunoprecipitations with
a-FLAG). Due to the FLAG tag, the molecular mass of AQP2-
S256D-F is higher than that of AQP2-S256A.Kamsteeg et al. Stoichiometry of (Non)phosphorylated AQP2 Subunits 925
monomers would be essential for AQP2 plasma membrane
localization, the expected concomitant Pf values for the dif-
ferent SA/SD ratios were calculated (columns AAAA
through DDDD in Table II, respectively).
Comparison between Expected and Observed Pf Values.
From three independent experiments, it appeared that the
observed Pf values fitted with the expected Pf values when
at least three out of four AQP2-S256D-F monomers were
present in an AQP2 heterotetramer (bold in Table II, P ,
0.05). This indicated that at least three AQP2-S256D-F
monomers are needed in an AQP2 tetramer for it to be lo-
calized in the plasma membrane.
Discussion
The primary structure of AQP2 contains one PKA, one
PKC, and three casein kinase II consensus sites (Fushimi
et al., 1993), but so far only PKA-mediated phosphoryla-
tion of S256 has been detected, which appeared to be es-
sential for the redistribution of AQP2 from intracellular
vesicles to the plasma membrane (Fushimi et al., 1997;
Katsura et al., 1997; Nishimoto et al., 1999). Surprising,
therefore, was the identification of p-AQP2 in intracellu-
lar vesicles of collecting ducts of rats that were not stimu-
lated with AVP (Christensen et al., 2000). Since AQP2 is
expressed as homotetramers (Kamsteeg et al., 1999), we
hypothesized that the number of phosphorylated AQP2
monomers in a tetramer might determine its main site of
expression.
Oocyte labeling with orthophosphate radioisotopes re-
vealed that, in the absence of exogenous stimulation, wt-
AQP2 was already labeled at S256 only (Fig. 1). The level
Figure 5. Semiquantification of the amounts and ratios of AQP2-
S256A and AQP2-S256D-F in coinjections. Copy RNAs encod-
ing AQP2-S256D-F and AQP2-S256A were mixed in the ratios 1:3,
1:2, 1:1, 2:1, and 3:1 (from left to right) and a total of 0. 4 ng was
injected into oocytes. 2 d later, the Pf values were determined
(see Table II) and total membranes were isolated and immuno-
blotted for AQP2. The individual signals of AQP2-S256A (SA)
and AQP2-S256D-F (SD) were scanned and the amounts of ex-
pressed protein were semiquantified (in arbitrary units) using the
scanned signals of a twofold dilution series of wt-AQP2 as a stan-
dard. From these data, the SD/SA ratio and total AQP2 amounts
were calculated.
Table I. Fractions of AQP2 Expected in the Plasma Membrane 
at Variable AQP2-S256D-F/AQP2-S256A Ratios
Fraction of protein in plasma membrane
Ratio SD/SA AAAA AAAD AADD ADDD DDDD
0.48 1 0.79 0.39 0.10 0.01
0.51 1 0.81 0.41 0.11 0.01
0.81 1 0.91 0.61 0.24 0.04
1.46 1 0.97 0.81 0.46 0.12
2.39 1 0.99 0.92 0.66 0.25
From the ratios of coexpressed AQP2-S256D-F (SD) and AQP2-S256A (SA) (see the
legend to Fig. 5), the frequencies of all five tetrameric forms of AQP2-S256D-F and/
or AQP2-S256A were calculated, assuming random formation of tetramers. From
these frequencies, the fraction of protein expected to be expressed in the plasma
membrane was calculated for when zero, one, two, three, or four AQP2-S256D-F
monomers per tetramer would be necessary for the plasma membrane localization of
AQP2 (AAAA, AAAD, AADD, ADDD, and DDDD, respectively).
Figure 6. The relation between the expressed amounts and con-
ferred water permeabilities of AQP2-S256D-F. Of oocytes, in-
jected with 0.1, 0.2, 0.3, or 0.4 ng of AQP2-S256D-F cRNA, the
water permeability (Pf 6 SEM in mm/s) was measured. Total
membranes were isolated and immunoblotted for AQP2 (AQP2-
S256D-F; insert). The signals were scanned and the amounts of
expressed AQP2-S256D-F (AQP2 amount in arbitrary units)
were semiquantified as described in the legend to Fig. 5. The lin-
ear relation between the amount of AQP2-S256D-F protein and
the conferred water permeability was: Pf = (3.97 3 amount of
AQP2 protein expected in membrane) 2 9. 7. For expression lev-
els lower than obtained for 0.1 ng AQP2-S256D-F cRNA, the re-
lation was extrapolated to the Pf level of control oocytes (8 6 4
mm/s, dotted line).
Table II. Expected and Observed Pf Values of Oocytes 
Coexpressing AQP2-S256D-F and AQP2-256A at
Variable Ratios
Expected Pf
Ratio SD/SA AAAA AAAD AADD ADDD DDDD Observed Pf
0.48 98 75 32 NS NS NS
0.51 102 80 36 NS NS NS
0.81 91 81 51 14 NS 23 6 6
1.46 76 74 60 30 NS 25 6 4
2.39 103 102 94 65 18 62 6 9
Control: 8 6 4
From the data in Figs. 5 and 6, and Table I, the expected Pfs (shown in mm/s) were
calculated for when zero, one, two, three, or four AQP2-S256D-F monomers per
tetramer would be necessary for a plasma membrane localization of AQP2 (AAAA,
AAAD, AADD, ADDD, and DDDD, respectively). The observed Pfs 6 SEM (shown
in mm/s) for the different coinjections and noninjected oocytes (Control) are mean
values of at least 12 oocytes. NS, expected and observed Pf values that were not
significantly different from noninjected control oocytes. SD, AQP2-S256D-F; SA,
AQP2-256A.The Journal of Cell Biology, Volume 151, 2000 926
of endogenous phosphorylation (Fig. 1) as well as the con-
ferred water permeability could neither be increased nor
decreased with cAMP or H89, respectively. It is well
known that Xenopus oocytes are blocked in the prophase I
stage of development by high intracellular cAMP levels
and active PKA, whereas a progesterone-induced reduc-
tion of cAMP levels initiates meiotic divisions (Jessus et
al., 1998). Therefore, the absence of an 8-Br-cAMP effect
in our study is presumably caused by high levels of endog-
enous cAMP in oocytes, which might also explain the ab-
sence of an inhibitory effect of H89 on PKA (Fig. 1). A
high endogenous cAMP level is underscored by the com-
plete plasma membrane localization of wt-AQP2 in un-
stimulated oocytes, whereas the nonphosphorylatable
mutant AQP2-S256A is localized below the plasma
membrane (Figs. 2 and 3). The high basal activity ob-
served for the ROMK1 potassium channel and the high
level of desensitization of the nicotinic acetylcholine re-
ceptor in oocytes have also been attributed to high endog-
enous cAMP levels (Hoffman et al., 1994; Xu et al., 1996).
However, our data are in contrast to those of others, who
observed an increase in AQP2-mediated Pf in oocytes, us-
ing an identical cAMP concentration and time frame (Ku-
wahara et al., 1995). A possible explanation for this differ-
ence is that their oocytes might have been exposed to a
progesterone-like hormone.
wt-AQP2 was completely localized in the plasma mem-
brane (Fig. 3) and was maximally phosphorylated at all
times. However, as phosphorylation and dephosphoryla-
tion of proteins is a dynamic process, wt-AQP2 in oocytes
will also be dephosphorylated. If at least three p-AQP2
monomers in a tetramer are be necessary for a steady state
localization of AQP2 in the plasma membrane, as shown
here, such a tetramer would show an identical localization
and functionality as a completely phosphorylated AQP2
tetramer. However, in a tetrameric complex of one AQP2-
S256A and three wt-AQP2 monomers, a phosphorylated
or nonphosphorylated wt-AQP2 monomer would then
greatly affect the steady state localization of the tetramer,
which would be an unnecessary complicating factor in the
determination of the stoichiometry of p-AQP2/non–
p-AQP2 in an AQP2 tetramer necessary for plasma mem-
brane expression. Therefore, the use of nonphosphorylat-
able AQP2 and continuously phosphorylated AQP2 was
desirable. Since an NH2-terminal FLAG tag did not inter-
fere with the routing and function of AQP2 (Yang and
Verkman, 1997; Kamsteeg et al., 1999), AQP2-S256A and
AQP2-S256D-F were used. However, the stoichiometry
could only be studied with these mutants if the three fol-
lowing prerequisites were fulfilled.
AQP2-S256A Should Be Predominantly Located in 
Vesicles, but Should Have a Single Channel Water 
Permeability Equal to That of wt-AQP2
Immunoblotting of total and plasma membranes (Fig. 2
B) together with immunocytochemistry (Fig. 3) clearly
showed that, when expressed at low levels, AQP2-S256A
was retained inside oocytes, possibly in vesicles. In view of
the supposed continuous cycling of membrane proteins,
the presence of some AQP2-S256A in the plasma mem-
branes was anticipated. These data are consistent with
transfected LLC-PK1 cells, in which the localization of
AQP2-S256A remained in intracellular vesicles after stim-
ulation with AVP (Fushimi et al., 1997; Katsura et al.,
1997). When expressed at high levels in oocytes, however,
a considerable amount of AQP2-S256A was located in the
plasma membrane (Mulders et al., 1998), which is likely to
be due to a saturation of the storing capacity of, and subse-
quent overflow from, the intracellular vesicles. Analysis of
these oocytes revealed that corresponding expression lev-
els of wt-AQP2 and AQP2-S256A in the plasma mem-
brane resulted in identical Pf values. Together, these data
indicate that AQP2-S256A in oocytes is properly folded, is
localized in an intracellular organelle, and has a single
channel water permeability identical to wt-AQP2. This is
in agreement with data from Lande et al. (1996), who
showed that phosphorylation of wt-AQP2 by PKA does
not change its single channel water permeability.
AQP2-S256D in Oocytes Should Behave Like wt-AQP2 
in Routing and Function
In oocytes, wt-AQP2 is maximally phosphorylated (Fig. 1).
A change of a phosphorylatable serine to aspartate has of-
ten been successfully used to mimic a phosphorylated state
of a protein (Rich et al., 1993; Huang and Erikson, 1994;
Kowlessur et al., 1995; Martinez et al., 1997). In this study,
where slight differences in plasma membrane expression
are detected as Pf differences, the predominant localiza-
tion and function of AQP2-S256D-F were indistinguish-
able from those of wt-AQP2 (Figs. 2 and 3). These results
strongly indicate that AQP2-S256D-F mimics p-AQP2.
AQP2-S256A and AQP2-S256D-F Should Randomly 
Form Heterotetramers
It was clearly shown that AQP2-S256A and AQP2-S256D-F
form heterotetramers upon coexpression in oocytes (Fig. 4
B). wt-AQP2, AQP2-S256A, AQP2-S256D, but also
AQP2-R253* (an AQP2 protein that misses the COOH-
terminal amino acids R253–T269; Mulders et al., 1998) ef-
ficiently formed homotetramers (Fig. 4 A) and, therefore,
the COOH-terminal tail of AQP2 at or close to S256 does
not seem to be involved in the oligomerization process.
For wt-AQP2, homotetramerization has been shown
previously (Kamsteeg et al., 1999). Possibly, the entire
COOH-terminal tail has no role in the oligomerization
process, because its sequence is not conserved among
AQPs while it has been shown that AQP0, 1, 2, and 4 form
homotetramers (Walz et al., 1997; Hasler et al., 1998;
Kamsteeg et al., 1999; Neely et al., 1999). Based on these
data, it is likely that heterotetramerization of AQP2-
S256A and AQP2-S256D-F occurs randomly.
Since all three requirements were fulfilled, AQP2-
S256A and AQP2-S256D-F could be used in oocytes to
determine the stoichiometry of p-AQP2/non–p-AQP2
monomers in an AQP2 tetramer required for a predomi-
nant localization in the plasma membrane. Comparison of
the expected and observed Pf values of oocytes, coexpress-
ing AQP2-S256A and AQP2-S256D-F in different ratios,
revealed that in AQP2 tetramers at least three out of four
AQP2-S256D-F monomers were needed for a plasma
membrane localization of AQP2 (Table II).
Interestingly, the Pf of oocytes coexpressing AQP2-
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expressing a similar amount of AQP2-S256D-F alone (not
shown). A similar effect on wt-AQP2 was observed in
oocytes coexpressing wt-AQP2 and AQP2-S256A (not
shown). Such a dominant-negative effect on the Pf of oo-
cytes coexpressing wt-AQP2 and AQP2-E258K, an AQP2
mutant in dominant NDI (Mulders et al., 1998), has recently
been shown to be due to the formation of heterotetramers
of the mutant and wild-type AQP2 proteins and subsequent
misrouting of this complex (Kamsteeg et al., 1999). From
the present observations it is anticipated that any mutation
disrupting the PKA consensus site, except possibly for
S256D or S256E, will cause dominant NDI in humans.
In renal collecting ducts, AQP2 resides in intracellular
vesicles at low cAMP levels and is redistributed to the api-
cal membrane after AVP addition (Deen and Knoers,
1998; Nielsen et al., 1999). Although detailed knowledge of
this translocation event is still lacking, this process shows
similarities to regulated exocytosis in neuronal synapses.
Several proteins that mediate docking and fusion of a vesi-
cle to its acceptor membrane (e.g., vesicle-associated mem-
brane protein 2 [VAMP-2], syntaxin-4, and SNAP23) have
been identified in collecting duct principal cells (Lieben-
hoff and Rosenthal, 1995; Nielsen et al., 1995b; Mandon et
al., 1996; Inoue et al., 1998; Marples et al., 1998; Valenti et
al., 1998). Additionally, specific blocking of PKA anchor-
ing proteins (AKAPs) in primary rat inner medullary col-
lecting duct cells strongly interfered with translocation of
AQP2 to the plasma membrane without affecting the cata-
lytic subunit of PKA (Klussmann et al., 1999). This indi-
cates that, besides the activity of PKA, its tethering to
subcellular compartments is also necessary for c-AMP–
dependent AQP2 translocation. It is not known whether in
oocytes any of these proteins play a role in AQP2 shuttling
to the plasma membrane, but the lack of wt-AQP2 accu-
mulation in intracellular vesicles, whether caused by high
activity of adenylyl cyclase and/or PKA or the absence of
proteins essential for AQP2 storage in vesicles, is a clear
difference between oocytes and mammalian cells. How-
ever, the apparently undisturbed routing of wt-AQP2 to
the plasma membrane in oocytes could and has been used
to its advantage in this study. The complete plasma mem-
brane localization of wt-AQP2 at basal conditions and the
retained localization of AQP2-S256A indicate that in oo-
cytes only S256 phosphorylation determines the subcellu-
lar localization of AQP2. Besides the involvement of other
proteins in the redistribution process of AQP2, such stud-
ies would be difficult to pursue in transfected epithelial
cells, because, in contrast to oocytes, the expression of het-
erologous proteins cannot be accurately controlled and,
based on immunocytochemical analyses, is quite variable
between neighboring stably transfected cells. Also, the
conferred Pf cannot be properly determined per cell.
Therefore, the oocyte might be the only cell system in
which the effects of the stoichiometry of p-AQP2 and non–
p-AQP2 monomers on the steady state subcellular local-
ization of the AQP2 tetramer can be studied.
Many, if not all, membrane proteins are continuously
transported between several organelles along microtubu-
lar and actin cytoskeletal systems (Ghosh et al., 1998;
Rohn et al., 2000; Sonnichsen et al., 2000). The predomi-
nant subcellular localization of the protein in such a dy-
namic equilibrium is then determined by several factors,
including the activity of protein kinases and phosphatases
(Zehavi-Feferman et al., 1995; Molloy et al., 1999; Bao et
al., 2000). In parallel, it has been shown that in renal col-
lecting duct and/or transfected cells, AQP2 is continuously
shuttled between intracellular vesicles and the apical
plasma membrane (Brown et al., 1988; Strange et al., 1988)
and that the predominant localization of AQP2 (in intra-
cellular vesicles or plasma membrane) in a steady state
(without or with AVP stimulation, respectively) is deter-
mined by whether AQP2 is phosphorylated or not (Wade
et al., 1981; Nielsen et al., 1995a; Sabolic et al., 1995;
Brown and Stow, 1996; Katsura et al., 1996, 1997; Chris-
tensen et al., 2000). Although it is clear that this site of
AQP2 phosphorylation concerns S256 (Fushimi et al.,
1997; Katsura et al., 1997), it is unknown whether the
steady state localization of AQP2 is realized by modula-
tion of the activity of PKA, a serine/threonine phos-
phatase, or both. Combining these data and the results
from the present study, the following model might be ap-
plicable to AQP2 in renal collecting ducts. In mammals
with low circulating AVP levels, the majority of AQP2
tetramers in resting collecting duct cells contain one to
two phosphorylated monomers and, therefore, AQP2 is
mainly localized in intracellular vesicles. Binding of AVP
to its V2 receptor then either activates PKA, inactivates
a serine/threonine phosphatase, or both. Consequently,
many AQP2 monomers are, besides other proteins, phos-
phorylated, shifting the stoichiometry of p-AQP2/
non–p-AQP2 in most AQP2 tetramers to 3:1 or 4:0, re-
spectively. As a result, vesicles containing these AQP2 tet-
ramers, which could also contain AQP2 tetramers with two
or fewer p-AQP2 monomers, fuse with the apical membrane.
In view of the continuous process of recycling of AQP2,
tetramers with fewer than three phosphorylated mono-
mers are then expected to accumulate faster in coated pits
to be internalized than those with three or more p-AQP2
monomers. Alternatively and as shown for the transferrin
receptor (Sonnichsen et al., 2000), AQP2 tetramers with
different numbers of p-AQP2 monomers might be com-
partmentalized in different vesicles of which only a subset
is exocytosed. Upon establishment of an AVP-stimulated
steady state, most AQP2 would then be localized in the
apical membrane. As our analyses are done in steady
states, our data do not provide information on whether the
eventual localization of AQP2 is regulated at the level of
endocytosis, exocytosis, or both. In addition, since the sub-
cellular localization of AQP2 in oocytes is regulated by
phosphorylation of S256 only, our model describes the ef-
fects of the stoichiometry of p-AQP2 and non–p-AQP2 on
the steady state localization of AQP2 tetramers and does
not exclude the possibility that in renal collecting ducts
other mechanisms may influence the localization of
AQP2, independent of its phosphorylation state. In fact,
the apical localization of non–p-AQP2 in transfected cells
upon incubation with the serine/threonine phosphatase in-
hibitor okadaic acid indeed provides support for the pres-
ence of a mechanism overruling pure regulation of the
subcellular localization of AQP2 by (de)phosphorylation
of its S256 (Valenti et al., 2000).
In conclusion, our results clearly indicate that (de)phos-
phorylation of just one (the third) monomer of an AQP2
tetramer is sufficient to change the predominant steadyThe Journal of Cell Biology, Volume 151, 2000 928
state localization of AQP2 from intracellular vesicles to
the plasma membrane and vice versa and thereby provide
an explanation for the fact that, although AQP2 needs to
be phosphorylated to be redistributed from intracellular
vesicles to the plasma membrane, AQP2 in intracellular
vesicles is already phosphorylated in unstimulated collect-
ing duct cells. In addition, this study shows for the first
time that a steady state localization of a multimeric
protein is determined by the stoichiometry of its phos-
phorylated and nonphosphorylated monomers. Many
membrane receptors and transport proteins (e.g., the
GABA[A] receptor, ACh receptor, CFTR chloride chan-
nels, ROMK potassium channels, and the ENaC sodium
channel) have been shown to be multimeric proteins, of
which the routing or function is regulated via phosphoryla-
tion by PKA or PKC (Hoffman et al., 1994; McNicholas et
al., 1994; Glowatzki et al., 1995; Lukacs et al., 1997; Cheng
et al., 1998; Eskandari et al., 1998; McDonald et al., 1998;
Shimkets et al., 1998). Based on our results with AQP2, it
can be anticipated that a small change in the stoichiometry
of phosphorylated and nonphosphorylated subunits in
these multimeric complexes might also fine-tune their sub-
cellular localization or activation.
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